New York State Common Retirement Fund’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-210
| Closed | -$1K | – | 3410 |
|
|
2023
Q2 | $1K | Sell |
210
-2,374
| -92% | -$11.3K | ﹤0.01% | 3354 |
|
|
2023
Q1 | $16K | Sell |
2,584
-16,257
| -86% | -$101K | ﹤0.01% | 3151 |
|
|
2022
Q4 | $115K | Sell |
18,841
-41
| -0.2% | -$250 | ﹤0.01% | 2918 |
|
|
2022
Q3 | $226K | Buy |
18,882
+103
| +0.5% | +$1.23K | ﹤0.01% | 2727 |
|
|
2022
Q2 | $237K | Sell |
18,779
-25
| -0.1% | -$316 | ﹤0.01% | 2718 |
|
|
2022
Q1 | $212K | Sell |
18,804
-13
| -0.1% | -$147 | ﹤0.01% | 2801 |
|
|
2021
Q4 | $333K | Buy |
18,817
+8,279
| +79% | +$147K | ﹤0.01% | 2652 |
|
|
2021
Q3 | $243K | Sell |
10,538
-2,573
| -20% | -$59.3K | ﹤0.01% | 2840 |
|
|
2021
Q2 | $305K | Buy |
13,111
+5,811
| +80% | +$135K | ﹤0.01% | 2839 |
|
|
2021
Q1 | $227K | Buy |
+7,300
| New | +$227K | ﹤0.01% | 2788 |
|